| 摘要 |
The present disclosure is directed to methods for providing tolperisone havi ng extremely low levels of 4-MMPPO (2-methyl-1-(4- methylphenyl)-propenone), as well as related compositions. The invention further relates to methods of treatin g a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO, among other features.
|
